Q9BR39 (JPH2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 96.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Junctophilin-2 Short name=JP-2 Alternative name(s): Junctophilin type 2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 696 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Junctophilins contribute to the formation of junctional membrane complexes (JMCs) which link the plasma membrane with the endoplasmic or sarcoplasmic reticulum in excitable cells. Provides a structural foundation for functional cross-talk between the cell surface and intracellular calcium release channels. JPH2 is necessary for proper intracellular Ca2+ signaling in cardiac myocytes via its involvement in ryanodine receptor-mediated calcium ion release. Contributes to the construction of skeletal muscle triad junctions. Ref.7 |
| Subcellular location | Cell membrane; Peripheral membrane protein By similarity. Endoplasmic reticulum membrane; Single-pass type IV membrane protein By similarity. Sarcoplasmic reticulum membrane; Single-pass type IV membrane protein By similarity. Note: Localized predominantly on the plasma membrane. The transmembrane domain is anchored in endoplasmic/sarcoplasmic reticulum membrane, while the N-terminal part associates with the plasma membrane. In heart cells, it predominantly associates along Z lines within myocytes. In skeletal muscle, it is specifically localized at the junction of A and I bands By similarity. |
| Tissue specificity | Specifically expressed in skeletal muscle and heart. Ref.4 |
| Domain | The MORN (membrane occupation and recognition nexus) repeats contribute to the plasma membrane binding, possibly by interacting with phospholipids By similarity. |
| Post-translational modification | Phosphorylation on Ser-165, probably by PKC, affects RYR1-mediated calcium ion release, interaction with TRPC3, and skeletal muscle myotubule development. |
| Involvement in disease | Defects in JPH2 are the cause of familial hypertrophic cardiomyopathy type 17 (CMH17) [MIM:613873]. CMH17 is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Ref.9 |
| Sequence similarities | Belongs to the junctophilin family. Contains 8 MORN repeats. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Endoplasmic reticulum Membrane Sarcoplasmic reticulum |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Cardiomyopathy Disease mutation |
| Domain | Repeat Transmembrane Transmembrane helix |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | calcium ion transport into cytosol Traceable author statement. Source: BHF-UCL positive regulation of ryanodine-sensitive calcium-release channel activityInferred from direct assay Ref.7. Source: UniProtKB |
| Cellular component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW junctional sarcoplasmic reticulum membraneTraceable author statement. Source: BHF-UCL plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | calcium-release channel activity Inferred from direct assay Ref.7. Source: UniProtKB protein bindingInferred from physical interaction Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9BR39-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9BR39-2) The sequence of this isoform differs from the canonical sequence as follows: 128-129: TY → MC 130-696: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 696 | 696 | Junctophilin-2 | PRO_0000159847 | |||||
Regions | |||||||||
| Topological domain | 1 – 674 | 674 | Cytoplasmic Potential | ||||||
| Transmembrane | 675 – 695 | 21 | Helical; Anchor for type IV membrane protein; Potential | ||||||
| Repeat | 14 – 36 | 23 | MORN 1 | ||||||
| Repeat | 38 – 59 | 22 | MORN 2 | ||||||
| Repeat | 60 – 79 | 20 | MORN 3 | ||||||
| Repeat | 82 – 104 | 23 | MORN 4 | ||||||
| Repeat | 106 – 128 | 23 | MORN 5 | ||||||
| Repeat | 129 – 151 | 23 | MORN 6 | ||||||
| Repeat | 291 – 313 | 23 | MORN 7 | ||||||
| Repeat | 314 – 336 | 23 | MORN 8 | ||||||
| Compositional bias | 3 – 142 | 140 | Gly-rich | ||||||
| Compositional bias | 373 – 408 | 36 | Ala-rich | ||||||
| Compositional bias | 452 – 633 | 182 | Pro-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 165 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 469 | 1 | Phosphoserine Ref.5 | ||||||
| Modified residue | 484 | 1 | Phosphoserine Ref.6 | ||||||
| Modified residue | 486 | 1 | Phosphoserine Ref.5 Ref.6 | ||||||
| Modified residue | 490 | 1 | Phosphothreonine Ref.5 Ref.6 | ||||||
Natural variations | |||||||||
| Alternative sequence | 128 – 129 | 2 | TY → MC in isoform 2. | VSP_002785 | |||||
| Alternative sequence | 130 – 696 | 567 | Missing in isoform 2. | VSP_002786 | |||||
| Natural variant | 101 | 1 | S → R in CMH17; affects intracellular calcium handling and homeostasis. Ref.9 | VAR_065471 | |||||
| Natural variant | 141 | 1 | Y → H in CMH17; results in vacuolization of intracellular structures and cardiomyocyte hypertrophy; affects intracellular calcium handling and homeostasis. Ref.9 | VAR_065472 | |||||
| Natural variant | 165 | 1 | S → F in CMH17; results in vacuolization of intracellular structures and cardiomyocyte hypertrophy; affects intracellular calcium handling and homeostasis. Greatly reduced phosphorylation. Increased myotube diameter. Reduced RYR1 activity and EC gain. Disruption of interaction with TRPC3. Ref.7 Ref.9 | VAR_065473 | |||||
| Natural variant | 396 | 1 | A → T. Corresponds to variant rs3810510 [ dbSNP | Ensembl ]. | VAR_053447 | |||||
| Natural variant | 436 | 1 | R → C. Ref.8 | VAR_065474 | |||||
| Natural variant | 505 | 1 | G → S in patients with cardiomyopathy; does not affect protein conformation as shown by circular dichroism; a patient with cardiomyopathy also carries V-26 and C-513 in MYH7. Ref.8 | VAR_065475 | |||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | Stavrides G.S., Huckle E.J., Deloukas P. Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [2] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed: 11780052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Characterization of human junctophilin subtype genes." Nishi M., Mizushima A., Nakagawara K., Takeshima H. Biochem. Biophys. Res. Commun. 273:920-927(2000) [PubMed: 10891348] [Abstract] Cited for: IDENTIFICATION (ISOFORM 1), TISSUE SPECIFICITY. |
| [5] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-469; SER-486 AND THR-490, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [6] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484; SER-486 AND THR-490, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [7] | "S165F mutation of junctophilin 2 affects Ca2+ signalling in skeletal muscle." Woo J.S., Hwang J.H., Ko J.K., Weisleder N., Kim do H., Ma J., Lee E.H. Biochem. J. 427:125-134(2010) [PubMed: 20095964] [Abstract] Cited for: PHOSPHORYLATION AT SER-165, INTERACTION WITH TRPC3, FUNCTION, CHARACTERIZATION OF VARIANT PHE-165. |
| [8] | "Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy." Matsushita Y., Furukawa T., Kasanuki H., Nishibatake M., Kurihara Y., Ikeda A., Kamatani N., Takeshima H., Matsuoka R. J. Hum. Genet. 52:543-548(2007) [PubMed: 17476457] [Abstract] Cited for: VARIANTS CYS-436 AND SER-505, CHARACTERIZATION OF VARIANT SER-505. |
| [9] | "Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans." Landstrom A.P., Weisleder N., Batalden K.B., Bos J.M., Tester D.J., Ommen S.R., Wehrens X.H., Claycomb W.C., Ko J.K., Hwang M., Pan Z., Ma J., Ackerman M.J. J. Mol. Cell. Cardiol. 42:1026-1035(2007) [PubMed: 17509612] [Abstract] Cited for: VARIANTS CMH17 ARG-101; HIS-141 AND PHE-165, CHARACTERIZATION OF VARIANTS CMH17 ARG-101; HIS-141 AND PHE-165. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AL132999 mRNA. Translation: CAB61347.1. AL035447, AL034419 Genomic DNA. Translation: CAI19380.1. AL034419, AL035447 Genomic DNA. Translation: CAI42199.1. AL035447 Genomic DNA. Translation: CAC18785.1. CH471077 Genomic DNA. Translation: EAW75940.1. CH471077 Genomic DNA. Translation: EAW75943.1. |
| IPI | IPI00176532. IPI00218603. |
| RefSeq | NP_065166.2. NM_020433.4. NP_787109.2. NM_175913.3. |
| UniGene | Hs.441737. |
3D structure databases | |
| ProteinModelPortal | Q9BR39. |
| SMR | Q9BR39. Positions 30-138, 287-356. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q9BR39. |
PTM databases | |
| PhosphoSite | Q9BR39. |
Polymorphism databases | |
| DMDM | 27805486. |
Proteomic databases | |
| PRIDE | Q9BR39. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000372980; ENSP00000362071; ENSG00000149596. |
| GeneID | 57158. |
| KEGG | hsa:57158. |
| UCSC | uc002xli.1. human. uc002xlj.1. human. |
Organism-specific databases | |
| CTD | 57158. |
| GeneCards | GC20M042740. |
| HGNC | HGNC:14202. JPH2. |
| MIM | 605267. gene. 613873. phenotype. |
| neXtProt | NX_Q9BR39. |
| Orphanet | 155. Familial isolated hypertrophic cardiomyopathy. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG07066. |
| GeneTree | ENSGT00600000084242. |
| HOGENOM | HBG715737. |
| HOVERGEN | HBG031648. |
| InParanoid | Q9BR39. |
| OMA | NTILICM. |
| OrthoDB | EOG4B8JDX. |
| PhylomeDB | Q9BR39. |
Gene expression databases | |
| ArrayExpress | Q9BR39. |
| Bgee | Q9BR39. |
| CleanEx | HS_JPH2. |
| Genevestigator | Q9BR39. |
| GermOnline | ENSG00000149596. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR017191. Junctophilin. IPR003409. MORN. [Graphical view] |
| Pfam | PF02493. MORN. 8 hits. [Graphical view] |
| PIRSF | PIRSF037387. Junctophilin. 1 hit. |
| SMART | SM00698. MORN. 6 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 63151. |
| SOURCE | Search... |
Entry information
| Entry name | JPH2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9BR39 Secondary accession number(s): E1P5X1 Q9UJN4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with